A Novel Technique of HALS With CME and CVL for RCC
Colon Neoplasms
About this trial
This is an interventional treatment trial for Colon Neoplasms focused on measuring hand-assisted laparoscopic surgery, right colon cancer, complete mesocolic excision, no touch isolation, recurrence, overall survival
Eligibility Criteria
Inclusion Criteria:
- Histologically confirmed right colon cancer
- Clinical stage: I, II, III
- No preoperative chemoradiotherapy
- No past surgical history
- No serious preoperative complication
- Eastern Cooperative Oncology Group (ECOG) performance status (PS): 0-1
- Age: 18-80
- Written informed consent
Exclusion Criteria:
- Malignant neoplasm of other sites (including transverse, descending, sigmoid colon cancer, and rectal cancer)
- Metastatic cancer
- Multiple cancer
- Serious complications (including bowel perforation, bowel obstruction, gastrointestinal hemorrhage)
- Pregnant and lactating women
- Psychological disorder
- Steroid administration
- Cardiac infarction within six months
- Severe pulmonary emphysema and pulmonary fibrosis
Sites / Locations
- West China hospital, Sichuan UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
No Intervention
No Intervention
Group A
Group B
Group C
The novel hand-assisted laparoscopic surgery with complete mesocolic excision and central vascular ligation for right colon cancer. In this group, greater omentum, transverse colon, and ileum were brought out through the hand-port incision at the beginning of the operation and divided extracorporeally.
novel laparoscopic surgery with complete mesocolic excision and central vascular ligation for right colon cancer. In this group, greater omentum, transverse colon, and ileum were divided at the beginning of the operation intracorporeally.
the traditional laparoscopic surgery with complete mesocolic excision and central vascular ligation for right colon cancer.